Drug profile · INN
turoctocog alfa pegol
ESPEROCT
turoctocog alfa pegol (ESPEROCT) is a coagulation factor viii exogenous protein.
EMA: approved Blood and blood forming organs (B02) B02BD02
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — turoctocog alfa pegol
- Class
- Blood and blood forming organs (B02)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
turoctocog alfa pegol (ESPEROCT) is a coagulation factor viii exogenous protein.
Key facts
INN turoctocog alfa pegol
Brand ESPEROCT
Mechanism Coagulation factor VIII exogenous protein
Target Coagulation factor VIII
Therapeutic class Blood and blood forming organs (B02)
ATC code B02BD02
Mechanism of action
Coagulation factor VIII exogenous protein
Primary target: Coagulation factor VIII
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is turoctocog alfa pegol?
turoctocog alfa pegol (ESPEROCT) is a coagulation factor viii exogenous protein.
What is the brand name for turoctocog alfa pegol?
ESPEROCT is a marketed brand name for turoctocog alfa pegol. Check FDA Drugs@FDA for the current US label holder and prescribing information.